Pioneering work by the Hurley group demonstrated that small molecules stabilizing G4 structures can inhibit c-MYC transcription, highlighting G4s as a promising anti-cancer target (Siddiqui-Jain et al.2002). The gene discussed is MYC; the disease is cancer.